Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 12/20 | 0.47 |
| ▸ | JAK2 | O60674 | 3/20 | 0.47 |
| ▸ | DYRK1A | Q13627 | 5/20 | 0.45 |
| ▸ | GSK3B | P49841 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26686009 | 1.00 | MAPK1 (0.47) | MAPK1JAK2DYRK1AGSK3B | |
| SCHEMBL31240475 | 0.89 | MAPK1 (0.57) | MAPK1JAK2DYRK1A | |
| SCHEMBL26685737 | 0.89 | MAPK1 (0.57) | MAPK1JAK2DYRK1A | |
| SCHEMBL26686173 | 0.88 | MAPK1 (0.56) | MAPK1JAK2DYRK1A | |
| SCHEMBL30633349 | 0.88 | MAPK1 (0.56) | MAPK1JAK2DYRK1A | |
| SCHEMBL31240315 | 0.86 | MAPK1 (0.56) | MAPK1JAK2DYRK1A | |
| SCHEMBL26685764 | 0.86 | MAPK1 (0.56) | MAPK1JAK2DYRK1A | |
| SCHEMBL30633327 | 0.86 | MAPK1 (0.60) | MAPK1 | |
| SCHEMBL26686017 | 0.86 | MAPK1 (0.60) | MAPK1 | |
| SCHEMBL30633294 | 0.86 | MAPK1 (0.49) | MAPK1JAK2DYRK1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4705291-A1 | IKK-ALPHA INHIBITORS | Cancer Research Technology Limited (GB) | 2026-03-11 | — | — | EP | claimed |
| CN-119562945-A | IKK inhibitors | 癌症研究技术有限公司 | 2025-03-04 | — | — | CN | claimed |
| WO-2024228035-A1 | IKK-ALPHA INHIBITORS | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2024-11-07 | — | — | WO | claimed |
| EP-4705291-A1 | IKK-ALPHA INHIBITORS | Cancer Research Technology Limited (GB) | 2026-03-11 | — | — | EP | disclosed |
| CN-119562945-A | IKK inhibitors | 癌症研究技术有限公司 | 2025-03-04 | — | — | CN | disclosed |
| WO-2024228035-A1 | IKK-ALPHA INHIBITORS | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2024-11-07 | — | — | WO | disclosed |